Gene-Edited Chickens: A New Defense Against Avian Influenza

Gene editing and artificial intelligence are reshaping poultry production in 2026, with CRISPR-based disease resistance and AI-driven flock management emerging as critical tools against avian influenza and industry challenges.

David Corredor

Gene editing and artificial intelligence are reshaping poultry production in 2026, with CRISPR-based disease resistance and AI-driven flock management emerging as critical tools against avian influenza and industry challenges.

Researchers at the University of Missouri are testing CRISPR technology to make chickens more resistant to highly pathogenic avian influenza (HPAI). The approach targets genes such as the ANP32 family, which play a role in viral replication. Early studies show reduced virus replication and transmission, though full immunity is not expected. The USDA reports that HPAI has caused the death or culling of over 200 million birds between 2022 and 2026, underscoring the urgency of new solutions¹.

Market and Regulatory Challenges

While promising, gene-edited poultry faces hurdles in consumer acceptance and regulatory approval. Many buyers still conflate gene editing with genetically modified organisms (GMOs), raising concerns about market adoption. Long-term safety, productivity, and performance across diverse strains must be proven before commercial rollout. Experts estimate widespread availability is still several years away¹.

AI and Automation: The Brain of Modern Poultry Farms

Beyond genetics, artificial intelligence (AI) is revolutionizing poultry farming. AI-powered monitoring systems now detect flock health issues before they become visible, improving disease prevention and efficiency. In 2026, AI is being integrated into hatcheries, broiler houses, and breeder operations, enabling predictive management and reducing reliance on manual observation. This shift is considered one of the fastest technology adoption cycles in poultry history².